# A Multiple Dose Safety Study of PEG-IFN in Healthy Volunteers

> **NCT02125578** · PHASE1 · COMPLETED · sponsor: **Biogen** · enrollment: 69 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BIIB017 (PEGylated Interferon Beta-1a)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02125578
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2014-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02125578

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02125578, "A Multiple Dose Safety Study of PEG-IFN in Healthy Volunteers". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT02125578. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*